Founder, President And Cto
CurrentResponsible for development, optimization and commercialization of Tymora Analytical primary technologies. Tymora Analytical Operations provides diagnostic development, contract services and products for improved cancer and other disease research. Tymora's primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow detection of active disease markers directly from plasma, urine or saliva.